CIK: 0001832749 · Show all filings
Period: Q4 2023 (← Previous) (Next →)
Filing Date: Feb 14, 2024
Total Value ($000): $22,520 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| KRRO | KORRO BIO INC | 276,831 | $13,269 | 58.9% | $32.95 | 0.0% | COM | 500946108 |
| CRBU | CARIBOU BIOSCIENCES INC | 474,067 | $2,716 | 12.1% | $24.45 | -79.8% | COM | 142038108 |
| TRDA | ENTRADA THERAPEUTICS INC | 172,600 | $2,605 | 11.6% | $17.12 | — | COM | 29384C108 |
| PRAX | PRAXIS PRECISION MEDICINES I | 65,933 | $1,469 | 6.5% | $18.01 | 0.0% | COM NEW | 74006W207 |
| — | TURNSTONE BIOLOGICS CORP | 549,981 | $1,400 | 6.2% | $3.94 | — | COM | 90042W100 |
| — | OMEGA THERAPEUTICS INC | 352,941 | $1,062 | 4.7% | $18.85 | — | COMMON STOCK | 68217N105 |